Sara Corvigno

1.0k total citations
37 papers, 466 citations indexed

About

Sara Corvigno is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Sara Corvigno has authored 37 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 9 papers in Reproductive Medicine. Recurrent topics in Sara Corvigno's work include Ovarian cancer diagnosis and treatment (9 papers), Cancer Cells and Metastasis (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sara Corvigno is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Cancer Cells and Metastasis (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sara Corvigno collaborates with scholars based in United States, Sweden and Italy. Sara Corvigno's co-authors include Artur Mezheyeuski, Arne Östman, Anil K. Sood, Agostina Nardone, Bianca Maria Veneziani, Jinsong Liu, Hanna Dahlstrand, Arne Östman, Sabino De Placido and Carina Strell and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Sara Corvigno

35 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Corvigno United States 13 228 226 146 74 67 37 466
Carmen Ghilardi Italy 14 243 1.1× 384 1.7× 178 1.2× 61 0.8× 55 0.8× 23 635
Lidia Moyano‐Galceran Sweden 12 330 1.4× 265 1.2× 155 1.1× 162 2.2× 86 1.3× 15 679
Salvatore A. Del Prete United States 10 374 1.6× 307 1.4× 154 1.1× 99 1.3× 99 1.5× 13 665
Lorena Alonso‐Alconada Spain 12 223 1.0× 247 1.1× 216 1.5× 55 0.7× 60 0.9× 20 478
Kirsty Ratcliffe United States 6 123 0.5× 243 1.1× 77 0.5× 31 0.4× 77 1.1× 7 385
Saima Hassan Canada 13 384 1.7× 400 1.8× 175 1.2× 162 2.2× 100 1.5× 27 735
Yong‐Jian Deng China 12 153 0.7× 237 1.0× 108 0.7× 68 0.9× 44 0.7× 21 424
Jordan F. Hastings Australia 8 127 0.6× 256 1.1× 106 0.7× 35 0.5× 49 0.7× 13 455
Neil Gray United Kingdom 8 138 0.6× 252 1.1× 76 0.5× 31 0.4× 68 1.0× 9 420
Scott A. Shell United States 10 167 0.7× 748 3.3× 473 3.2× 61 0.8× 91 1.4× 20 1.0k

Countries citing papers authored by Sara Corvigno

Since Specialization
Citations

This map shows the geographic impact of Sara Corvigno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Corvigno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Corvigno more than expected).

Fields of papers citing papers by Sara Corvigno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Corvigno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Corvigno. The network helps show where Sara Corvigno may publish in the future.

Co-authorship network of co-authors of Sara Corvigno

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Corvigno. A scholar is included among the top collaborators of Sara Corvigno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Corvigno. Sara Corvigno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Lopamudra, et al.. (2024). Angiogenesis‐Enabled Human Ovarian Tumor Microenvironment‐Chip Evaluates Pathophysiology of Platelets in Microcirculation. Advanced Healthcare Materials. 13(19). e2304263–e2304263. 8 indexed citations
2.
Corvigno, Sara, Yuan Liu, Emine Bayraktar, et al.. (2024). Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy. npj Precision Oncology. 8(1). 86–86. 18 indexed citations
3.
Corvigno, Sara, Nicole D. Fleming, Shannon N. Westin, et al.. (2024). Finding a needle in the haystack: Identifying risk of MDS/AML after PARP inhibitor treatment. Gynecologic Oncology. 190. S44–S45.
4.
Sköld, Camilla, Sara Corvigno, Hanna Dahlstrand, et al.. (2024). Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer. Cancer Causes & Control. 35(8). 1101–1109. 2 indexed citations
5.
Bayraktar, Emine, et al.. (2024). Ovarian cancer metastasis: Looking beyond the surface. Cancer Cell. 42(10). 1631–1636. 13 indexed citations
6.
Wu, Xinyu, et al.. (2024). Rapid Hyperspectral Photothermal Mid-Infrared Spectroscopic Imaging from Sparse Data for Gynecologic Cancer Tissue Subtyping. Analytical Chemistry. 96(40). 15880–15887. 4 indexed citations
7.
Stur, Elaine, Fuduan Peng, Pang-ning Teng, et al.. (2023). Abstract 5782: The dynamic immune behavior of primary and metastatic tumors of ovarian cancer. Cancer Research. 83(7_Supplement). 5782–5782. 1 indexed citations
8.
Corvigno, Sara, Kwong‐Kwok Wong, Min Soon Cho, et al.. (2022). Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles. Molecular Cancer Therapeutics. 21(7). 1067–1075. 14 indexed citations
9.
Stur, Elaine, Sara Corvigno, Mingchu Xu, et al.. (2022). Spatially resolved transcriptomics of high-grade serous ovarian carcinoma. iScience. 25(3). 103923–103923. 42 indexed citations
10.
Wu, Yutuan, Nicholas B. Jennings, Yunjie Sun, et al.. (2022). Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer. Journal of Cancer Research and Clinical Oncology. 148(4). 803–821. 9 indexed citations
11.
Corvigno, Sara, Jared K. Burks, Wei Hu, et al.. (2021). Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status. Journal of Cancer Research and Clinical Oncology. 147(12). 3545–3555. 6 indexed citations
12.
Wen, Yunfei, Ying Wang, Anca Chelariu-Raicu, et al.. (2020). Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1–Mediated Cell Death in Uterine Cancer. Molecular Cancer Therapeutics. 19(9). 1943–1954. 4 indexed citations
13.
Chen, Yang, Yifan Zhang, Yi Chen, et al.. (2020). Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers. PLoS ONE. 15(7). e0236291–e0236291. 12 indexed citations
14.
Corvigno, Sara, Artur Mezheyeuski, Sofia Westbom-Fremer, et al.. (2020). High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer. Gynecologic Oncology. 159(3). 860–868. 6 indexed citations
15.
Lara, Olivia D., Zhihui Wang, Sara Corvigno, et al.. (2019). Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma. Scientific Reports. 9(1). 17589–17589. 16 indexed citations
16.
Östman, Arne & Sara Corvigno. (2018). Microvascular Mural Cells in Cancer. Trends in cancer. 4(12). 838–848. 12 indexed citations
17.
Leccia, F., Agostina Nardone, Sara Corvigno, et al.. (2012). Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry Part A. 81A(11). 960–972. 35 indexed citations
18.
Nardone, Agostina, et al.. (2010). Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions. Cytotechnology. 63(1). 67–80. 10 indexed citations
19.
Cavaliere, Carla, Sara Corvigno, Mario Galgani, et al.. (2010). Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. Cancer Science. 101(7). 1661–1669. 9 indexed citations
20.
Nardone, Agostina, Carla Cavaliere, Sara Corvigno, et al.. (2009). A banking strategy toward customized therapy in breast cancer. Cell and Tissue Banking. 10(4). 301–308. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Ghilardi Breakdown of academic impact, for papers by Lidia Moyano‐Galceran Breakdown of academic impact, for papers by Salvatore A. Del Prete Breakdown of academic impact, for papers by Lorena Alonso‐Alconada Breakdown of academic impact, for papers by Kirsty Ratcliffe Breakdown of academic impact, for papers by Saima Hassan Breakdown of academic impact, for papers by Yong‐Jian Deng Breakdown of academic impact, for papers by Jordan F. Hastings Breakdown of academic impact, for papers by Neil Gray Breakdown of academic impact, for papers by Scott A. Shell
Rankless by CCL
2026